Certara scientists helped Roche apply an integrated clinical pharmacology program to support the development and global approval of Tamiflu for infants.
Scientists at the Aarhus University in Denmark used the Simcyp Simulator to support a forensic toxicological assessment of a fatal drug poisoning case.
Certara scientists deliver an integrated solution that helps Intercept Pharmaceuticals achieve FDA approval for Ocaliva.
Scientists at Washington State University and the University of North Carolina at Greensboro used Certara’s Phoenix WinNonlin and Simcyp Simulator to evaluate a previously unexplored herb- drug interaction mechanism.
A medium-sized biopharmaceutical company leveraged Certara’s trial simulation software and PBPK modeling and simulation consulting services to facilitate regulatory approval for a long- acting injectable antipsychotic drug.
A top-10 pharma company leveraged Certara’s regulatory writing services to ensure clinical data is published in a timely manner, objective, accurate, and balanced, regardless of the trial outcome.
A top-10 pharmaceutical company used Certara’s regulatory writing services to become the most transparent company in the industry.
A global CRO used Certara’s Phoenix Connect and Phoenix Knowledgebase Server Online to streamline their data management and analysis workflow.
Learn how the pre-clinical group at Gilead saved time and money by using Certara’s Phoenix WinNonlin and Phoenix Connect.